Article (Scientific journals)
Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome
Besnard, T.; Sloboda, N.; Goldenberg, A. et al.
2019In Genetics in Medicine, 21 (9), p. 2025-2035
Peer Reviewed verified by ORBi
 

Files


Full Text
Biallelic-pathogenic-variants-in-the-lanosterol-synthase-gene-LSS-involved-in-the-cholesterol-biosynthesis-cause-alopecia-2019Genetics-in-Medicine.pdf
Publisher postprint (1.42 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
LSS; Article; LSS gene; Sanger sequencing; Age of Onset; Alopecia; Child; Child, Preschool; Cholesterol; Developmental Disabilities; Epilepsy; Female; Humans; Infant; Intellectual Disability; Intramolecular Transferases; Lanosterol; Male; Mutation; Pedigree; Phenotype; Squalene; Whole Exome Sequencing
Abstract :
[en] Purpose: Lanosterol synthase (LSS) gene was initially described in families with extensive congenital cataracts. Recently, a study has highlighted LSS associated with hypotrichosis simplex. We expanded the phenotypic spectrum of LSS to a recessive neuroectodermal syndrome formerly named alopecia with mental retardation (APMR) syndrome. It is a rare autosomal recessive condition characterized by hypotrichosis and intellectual disability (ID) or developmental delay (DD), frequently associated with early-onset epilepsy and other dermatological features. Methods: Through a multicenter international collaborative study, we identified LSS pathogenic variants in APMR individuals either by exome sequencing or LSS Sanger sequencing. Splicing defects were assessed by transcript analysis and minigene assay. Results: We reported ten APMR individuals from six unrelated families with biallelic variants in LSS. We additionally identified one affected individual with a single rare variant in LSS and an allelic imbalance suggesting a second event. Among the identified variants, two were truncating, seven were missense, and two were splicing variants. Quantification of cholesterol and its precursors did not reveal noticeable imbalance. Conclusion: In the cholesterol biosynthesis pathway, lanosterol synthase leads to the cyclization of (S)-2,3-oxidosqualene into lanosterol. Our data suggest LSS as a major gene causing a rare recessive neuroectodermal syndrome. © 2019, American College of Medical Genetics and Genomics.
Disciplines :
Genetics & genetic processes
Author, co-author :
Besnard, T.;  CHU de Nantes, Service de Génétique Médicale, Nantes, France, L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France
Sloboda, N.;  INSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France
Goldenberg, A.;  Department of Genetics, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France
Küry, S.;  CHU de Nantes, Service de Génétique Médicale, Nantes, France, L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France
Cogné, B.;  CHU de Nantes, Service de Génétique Médicale, Nantes, France, L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France
Breheret, F.;  CHU de Nantes, Service de Génétique Médicale, Nantes, France
Trochu, E.;  CHU de Nantes, Service de Génétique Médicale, Nantes, France
Conrad, S.;  CHU de Nantes, Service de Génétique Médicale, Nantes, France
Vincent, M.;  CHU de Nantes, Service de Génétique Médicale, Nantes, France, L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France
Deb, W.;  CHU de Nantes, Service de Génétique Médicale, Nantes, France, L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France
Balguerie, X.;  Department of Dermatology, University Hospital Center of Rouen, Rouen, France
Barbarot, S.;  CHU de Nantes, Department of Dermatology, Nantes, France
Baujat, G.;  Department of Medical Genetics, INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, IMAGINE Institute, Necker Enfants Malades Hospital, Paris, France
Ben-Omran, T.;  Section of Clinical and Metabolic Genetics, Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar
Bursztejn, A.-C.;  Dermatology department, hôpital Brabois, Vandœuvre-lès-Nancy, Vandœuvre-Lès, France
Carmignac, V.;  Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l’Est, FHU-TRANSLAD, CHU Dijon, Dijon, France, UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France
Datta, A. N.;  Department of Pediatric Neurology and Developmental Medicine, University of Basel Children’s Hospital (UKBB), Basel, Switzerland
Delignières, A.;  CH Auray-Vannes, Hôpital Bretagne Atlantique, Service de Pediatrie, Vannes, France
Faivre, L.;  Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l’Est, FHU-TRANSLAD, CHU Dijon, Dijon, France, UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France
Gardie, B.;  L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France, Ecole Pratique des Hautes Etudes, PSL Research University, Paris, France
Guéant, J.-L.;  INSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France
Kuentz, P.;  Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l’Est, FHU-TRANSLAD, CHU Dijon, Dijon, France, UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France
Lenglet, M.;  L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France, Ecole Pratique des Hautes Etudes, PSL Research University, Paris, France
Nassogne, M.-C.;  Pediatric Neurology Unit, Cliniques Universitaires Saint-Luc, Universite Catholique de Louvain, Brussels, Belgium
RAMAEKERS, Vincent ;  Université de Liège - ULg
Schnur, R. E.;  GeneDx, 207 Perry Parkway, Gaithersburg, MD, United States
Si, Y.;  GeneDx, 207 Perry Parkway, Gaithersburg, MD, United States
Torti, E.;  GeneDx, 207 Perry Parkway, Gaithersburg, MD, United States
Thevenon, J.;  Centre de Génétique, Hôpital Couple-Enfant, CHU de Grenoble-Alpes, La Tronche, France
Vabres, P.;  Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l’Est, FHU-TRANSLAD, CHU Dijon, Dijon, France, UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France
Van Maldergem, L.;  Centre de génétique humaine, Université de Franche-Comté, Besançon, France, Integrative and Cognitive Neurosciences Research Unit EA481, University of Franche-Comté, Besançon, France
Wand, D.;  Department Medical Genetic and Pathology, University Hospital of Basel (USB), Basel, Switzerland
Wiedemann, A.;  INSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France
Cariou, B.;  L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France
Redon, R.;  L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France
Lamazière, A.;  Laboratory of Mass Spectrometry, INSERM ERL 1157, CNRS UMR 7203 LBM, Sorbonne Universités-UPMC, CHU Saint-Antoine, Paris, France
Bézieau, S.;  CHU de Nantes, Service de Génétique Médicale, Nantes, France, L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France
Feillet, F.;  INSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France
Isidor, B.;  CHU de Nantes, Service de Génétique Médicale, Nantes, France, L’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France
More authors (29 more) Less
Language :
English
Title :
Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome
Publication date :
2019
Journal title :
Genetics in Medicine
ISSN :
1098-3600
eISSN :
1530-0366
Publisher :
Lippincott Williams & Wilkins, United States
Volume :
21
Issue :
9
Pages :
2025-2035
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 21 May 2021

Statistics


Number of views
41 (2 by ULiège)
Number of downloads
2 (2 by ULiège)

Scopus citations®
 
43
Scopus citations®
without self-citations
42
OpenCitations
 
24

Bibliography


Similar publications



Contact ORBi